Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Recipharm has launched its end-to-end inhalation offering to provide customers with a fully integrated service from early stage development through to commercial manufacturing.
read more
Global contract development and manufacturing organisation (CDMO), Recipharm, has announced the completion of a new analytical laboratory at its facility in Bengaluru, India. The new lab has been in operation since August 1 2021.
read more
Thursday, November 14, 2019
Recipharm has announced it is joining the AMR Industry Alliance to contribute to exploring solutions to tackle growing concerns around antimicrobial resistance.
read more
Recipharm Venture Fund AB has together with Östersjöstiftelsen and Praktikerinvest made a joint investment of SEK 28 million in Pharmanest AB
read more
Wednesday, February 23, 2022
Recipharm is investing to expand its sterile fill and finish production capabilities at its site in Monts, France. The manufacturing facility which specializes in the aseptic filling of pharmaceutical products, including biologics into vials and ...
read more
Wednesday, November 02, 2016
Recipharm has announced an investment of over €1.2 million to enhance its small scale GMP active pharmaceutical ingredient (API) development and manufacturing capabilities in Paderno Dugnano, Italy.
read more
Recipharm has established a dedicated taskforce to manage the potential impact of Brexit on its organization.
read more
Thursday, December 10, 2020
Recipharm has announced an investment and capacity expansion at its facility in Israel.
read more
Recipharm has announced a €3.7 million investment to expand its lyophilization capacity in Masate, Italy, in response to growing customer demand.
read more
Recipharm has announced an €18 million investment to expand its blow fill seal (BFS) capacity at its site in Kaysersberg, France
read more
Wednesday, February 17, 2021
Recipharm, has extended its manufacturing license to include immunology products.
read more
Wednesday, August 31, 2016
Recipharm, the contract development and manufacturing organization (CDMO), has entered into a long term supply agreement with Tillotts Pharma AG.
read more
Wednesday, October 08, 2025
Recipharm has designated its Cuxhaven, Germany facility as a Centre of Excellence for analytical services supporting advanced therapy medicinal products (ATMPs) and biologics. The site now operates 500 m² of CGMP-compliant laboratories designed to ...
read more
Wednesday, December 20, 2023
Veeva Systems has revealed that Recipharm, a prominent global contract development and manufacturing organization (CDMO), will optimize its quality operations using Veeva Vault QMS, Veeva Vault QualityDocs, and Veeva Vault Training.
read more
Wednesday, March 14, 2012
Recipharm and ViroPharma today signed a commercial contract to initiate supply of Plenadren® for named patient use. In addition, ViroPharma are investing in capital equipment at the Recipharm manufacturing site - enabling large scale manufacturing ...
read more